Global Amblyopia Treatment Market

Amblyopia Treatment Comprehensive Study by Application (Hospital, Pharmacy, Opthalmic Clinic), Modern Treatment (Dig Rush, Falling Blocks, I-BiT, Occlu-Pad or Occlu-Tab, Vivid Vision, Others), Classical (Optical Correction, Patching, Pharmacological Treatment, Perceptual Learning), Amblyopia (Deprivation Amblyopia, Anisometropic Amblyopia, Strabismic Amblyopia, Reverse Amblyopia, Others) Players and Region - Global Market Outlook to 202

Amblyopia Treatment Market by XX Submarkets | Forecast Years 2023-202  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Amblyopia is majorly affected in early childhood. Its symptoms include a wandering eye, eyes that may not appear to work together, or poor depth perception. Today it is affecting up to 3.7% of the global population. Amblyopia is also known as the lazy eye. With the increase in investment in research and development clinicians are interested in new binocular treatments because of the rapid development in new technologies. There are various therapies are emerging in this amblyopia treatment industry. According to the industry experts, the North American region is expected to capture a major market share because of the increase in the number of cases and rising awareness towards treatment areas.This growth is primarily driven by Nearly 3% of Amblyopia Treatment Remain Untreated .

AttributesDetails
Study Period2018-202
Base Year2022
Forecast Period2023-202
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as 3M (United States), Vivid Vision, Inc. (United States), NovaSight (Israel), RevitalVision (Israel), Hilco Vision (United States), Krafty Eye Patches (United States), Fresnel Prism and Lens Co. (United States), OpthoPatch (United States), Lancastle International Ltd. (United Kingdom) and HOYA Vision Care Company (Thailand), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In Apr 2020, Novartis acquired Amblyotech, specialized in treatment and diagnosis of Amblyopia. After acquisition Novartis build novel technology for treatment of amblyopia. This acquisition helped company to expand its presence in amblyopia treatment market
In Mar 2021, The Israeli start-up specializing in ground-breaking vision care solutions based on AI and eye-tracking technology revealed that they got approval for its CureSight™ lazy eye digital treatment device.The providers are operating in this market are exploring their reach across various geographical regions by accepting mergers & acquisitions, expansions, investments, new product launches, and others. The market players are rapidly exploring new areas of expansion and growth across the globe to avail a competitive advantage through combined synergies.

Influencing Trend:
Atropine Sulfate Eye Drops are Widely Used for the Treatment of Amblyopia

Market Growth Drivers:
Nearly 3% of Amblyopia Treatment Remain Untreated and Growing Demand in the Asia Pacific Regions Because of Increase in Population

Challenges:
The Rise in Concern towards Amblyopia Treatment

Restraints:
Lack of Awareness

Opportunities:
Emerging Therapies for Amblyopia and Perceptual Learning Represent an Opportunity to Treat Adults with Amblyopia

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Amblyopia Treatment Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Amblyopia Treatment Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Amblyopia Treatment players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Amblyopia Treatment Study Sheds Light on
— The Amblyopia Treatment Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Amblyopia Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Amblyopia Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Hospital
  • Pharmacy
  • Opthalmic Clinic
By Modern Treatment
  • Dig Rush
  • Falling Blocks
  • I-BiT
  • Occlu-Pad or Occlu-Tab
  • Vivid Vision
  • Others

By Classical
  • Optical Correction
  • Patching
  • Pharmacological Treatment
  • Perceptual Learning

By Amblyopia
  • Deprivation Amblyopia
  • Anisometropic Amblyopia
  • Strabismic Amblyopia
  • Reverse Amblyopia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Nearly 3% of Amblyopia Treatment Remain Untreated
      • 3.2.2. Growing Demand in the Asia Pacific Regions Because of Increase in Population
    • 3.3. Market Challenges
      • 3.3.1. The Rise in Concern towards Amblyopia Treatment
    • 3.4. Market Trends
      • 3.4.1. Atropine Sulfate Eye Drops are Widely Used for the Treatment of Amblyopia
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amblyopia Treatment, by Application, Modern Treatment, Classical, Amblyopia and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Amblyopia Treatment (Value)
      • 5.2.1. Global Amblyopia Treatment by: Application (Value)
        • 5.2.1.1. Hospital
        • 5.2.1.2. Pharmacy
        • 5.2.1.3. Opthalmic Clinic
      • 5.2.2. Global Amblyopia Treatment by: Modern Treatment (Value)
        • 5.2.2.1. Dig Rush
        • 5.2.2.2. Falling Blocks
        • 5.2.2.3. I-BiT
        • 5.2.2.4. Occlu-Pad or Occlu-Tab
        • 5.2.2.5. Vivid Vision
        • 5.2.2.6. Others
      • 5.2.3. Global Amblyopia Treatment by: Classical (Value)
        • 5.2.3.1. Optical Correction
        • 5.2.3.2. Patching
        • 5.2.3.3. Pharmacological Treatment
        • 5.2.3.4. Perceptual Learning
      • 5.2.4. Global Amblyopia Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Amblyopia Treatment (Price)
  • 6. Amblyopia Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vivid Vision, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NovaSight (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. RevitalVision (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hilco Vision (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Krafty Eye Patches (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fresnel Prism and Lens Co. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. OpthoPatch (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lancastle International Ltd. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HOYA Vision Care Company (Thailand)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Amblyopia Treatment Sale, by Application, Modern Treatment, Classical, Amblyopia and Region (value and price ) (197-202)
    • 7.1. Introduction
    • 7.2. Global Amblyopia Treatment (Value)
      • 7.2.1. Global Amblyopia Treatment by: Application (Value)
        • 7.2.1.1. Hospital
        • 7.2.1.2. Pharmacy
        • 7.2.1.3. Opthalmic Clinic
      • 7.2.2. Global Amblyopia Treatment by: Modern Treatment (Value)
        • 7.2.2.1. Dig Rush
        • 7.2.2.2. Falling Blocks
        • 7.2.2.3. I-BiT
        • 7.2.2.4. Occlu-Pad or Occlu-Tab
        • 7.2.2.5. Vivid Vision
        • 7.2.2.6. Others
      • 7.2.3. Global Amblyopia Treatment by: Classical (Value)
        • 7.2.3.1. Optical Correction
        • 7.2.3.2. Patching
        • 7.2.3.3. Pharmacological Treatment
        • 7.2.3.4. Perceptual Learning
      • 7.2.4. Global Amblyopia Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Amblyopia Treatment (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amblyopia Treatment: by Application(USD Million)
  • Table 2. Amblyopia Treatment Hospital , by Region USD Million (2017-2022)
  • Table 3. Amblyopia Treatment Pharmacy , by Region USD Million (2017-2022)
  • Table 4. Amblyopia Treatment Opthalmic Clinic , by Region USD Million (2017-2022)
  • Table 5. Amblyopia Treatment: by Modern Treatment(USD Million)
  • Table 6. Amblyopia Treatment Dig Rush , by Region USD Million (2017-2022)
  • Table 7. Amblyopia Treatment Falling Blocks , by Region USD Million (2017-2022)
  • Table 8. Amblyopia Treatment I-BiT , by Region USD Million (2017-2022)
  • Table 9. Amblyopia Treatment Occlu-Pad or Occlu-Tab , by Region USD Million (2017-2022)
  • Table 10. Amblyopia Treatment Vivid Vision , by Region USD Million (2017-2022)
  • Table 11. Amblyopia Treatment Others , by Region USD Million (2017-2022)
  • Table 12. Amblyopia Treatment: by Classical(USD Million)
  • Table 13. Amblyopia Treatment Optical Correction , by Region USD Million (2017-2022)
  • Table 14. Amblyopia Treatment Patching , by Region USD Million (2017-2022)
  • Table 15. Amblyopia Treatment Pharmacological Treatment , by Region USD Million (2017-2022)
  • Table 16. Amblyopia Treatment Perceptual Learning , by Region USD Million (2017-2022)
  • Table 17. South America Amblyopia Treatment, by Country USD Million (2017-2022)
  • Table 18. South America Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 19. South America Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 20. South America Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 21. South America Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 22. Brazil Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 23. Brazil Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 24. Brazil Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 25. Brazil Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 26. Argentina Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 27. Argentina Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 28. Argentina Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 29. Argentina Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 30. Rest of South America Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 32. Rest of South America Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 33. Rest of South America Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 34. Asia Pacific Amblyopia Treatment, by Country USD Million (2017-2022)
  • Table 35. Asia Pacific Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 37. Asia Pacific Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 38. Asia Pacific Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 39. China Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 40. China Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 41. China Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 42. China Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 43. Japan Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 44. Japan Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 45. Japan Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 46. Japan Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 47. India Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 48. India Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 49. India Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 50. India Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 51. South Korea Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 52. South Korea Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 53. South Korea Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 54. South Korea Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 55. Taiwan Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 56. Taiwan Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 57. Taiwan Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 58. Taiwan Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 59. Australia Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 60. Australia Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 61. Australia Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 62. Australia Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 67. Europe Amblyopia Treatment, by Country USD Million (2017-2022)
  • Table 68. Europe Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 69. Europe Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 70. Europe Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 71. Europe Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 72. Germany Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 73. Germany Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 74. Germany Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 75. Germany Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 76. France Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 77. France Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 78. France Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 79. France Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 80. Italy Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 81. Italy Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 82. Italy Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 83. Italy Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 84. United Kingdom Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 85. United Kingdom Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 86. United Kingdom Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 87. United Kingdom Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 88. Netherlands Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 89. Netherlands Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 90. Netherlands Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 91. Netherlands Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 92. Rest of Europe Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 93. Rest of Europe Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 94. Rest of Europe Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 95. Rest of Europe Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 96. MEA Amblyopia Treatment, by Country USD Million (2017-2022)
  • Table 97. MEA Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 98. MEA Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 99. MEA Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 100. MEA Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 101. Middle East Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 102. Middle East Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 103. Middle East Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 104. Middle East Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 105. Africa Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 106. Africa Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 107. Africa Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 108. Africa Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 109. North America Amblyopia Treatment, by Country USD Million (2017-2022)
  • Table 110. North America Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 111. North America Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 112. North America Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 113. North America Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 114. United States Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 115. United States Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 116. United States Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 117. United States Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 118. Canada Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 119. Canada Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 120. Canada Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 121. Canada Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 122. Mexico Amblyopia Treatment, by Application USD Million (2017-2022)
  • Table 123. Mexico Amblyopia Treatment, by Modern Treatment USD Million (2017-2022)
  • Table 124. Mexico Amblyopia Treatment, by Classical USD Million (2017-2022)
  • Table 125. Mexico Amblyopia Treatment, by Amblyopia USD Million (2017-2022)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Amblyopia Treatment: by Application(USD Million)
  • Table 137. Amblyopia Treatment Hospital , by Region USD Million (197-202)
  • Table 138. Amblyopia Treatment Pharmacy , by Region USD Million (197-202)
  • Table 139. Amblyopia Treatment Opthalmic Clinic , by Region USD Million (197-202)
  • Table 140. Amblyopia Treatment: by Modern Treatment(USD Million)
  • Table 141. Amblyopia Treatment Dig Rush , by Region USD Million (197-202)
  • Table 142. Amblyopia Treatment Falling Blocks , by Region USD Million (197-202)
  • Table 143. Amblyopia Treatment I-BiT , by Region USD Million (197-202)
  • Table 144. Amblyopia Treatment Occlu-Pad or Occlu-Tab , by Region USD Million (197-202)
  • Table 145. Amblyopia Treatment Vivid Vision , by Region USD Million (197-202)
  • Table 146. Amblyopia Treatment Others , by Region USD Million (197-202)
  • Table 147. Amblyopia Treatment: by Classical(USD Million)
  • Table 148. Amblyopia Treatment Optical Correction , by Region USD Million (197-202)
  • Table 149. Amblyopia Treatment Patching , by Region USD Million (197-202)
  • Table 150. Amblyopia Treatment Pharmacological Treatment , by Region USD Million (197-202)
  • Table 151. Amblyopia Treatment Perceptual Learning , by Region USD Million (197-202)
  • Table 152. South America Amblyopia Treatment, by Country USD Million (197-202)
  • Table 153. South America Amblyopia Treatment, by Application USD Million (197-202)
  • Table 154. South America Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 155. South America Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 156. South America Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 157. Brazil Amblyopia Treatment, by Application USD Million (197-202)
  • Table 158. Brazil Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 159. Brazil Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 160. Brazil Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 161. Argentina Amblyopia Treatment, by Application USD Million (197-202)
  • Table 162. Argentina Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 163. Argentina Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 164. Argentina Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 165. Rest of South America Amblyopia Treatment, by Application USD Million (197-202)
  • Table 166. Rest of South America Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 167. Rest of South America Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 168. Rest of South America Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 169. Asia Pacific Amblyopia Treatment, by Country USD Million (197-202)
  • Table 170. Asia Pacific Amblyopia Treatment, by Application USD Million (197-202)
  • Table 171. Asia Pacific Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 172. Asia Pacific Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 173. Asia Pacific Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 174. China Amblyopia Treatment, by Application USD Million (197-202)
  • Table 175. China Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 176. China Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 177. China Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 178. Japan Amblyopia Treatment, by Application USD Million (197-202)
  • Table 179. Japan Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 180. Japan Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 181. Japan Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 182. India Amblyopia Treatment, by Application USD Million (197-202)
  • Table 183. India Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 184. India Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 185. India Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 186. South Korea Amblyopia Treatment, by Application USD Million (197-202)
  • Table 187. South Korea Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 188. South Korea Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 189. South Korea Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 190. Taiwan Amblyopia Treatment, by Application USD Million (197-202)
  • Table 191. Taiwan Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 192. Taiwan Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 193. Taiwan Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 194. Australia Amblyopia Treatment, by Application USD Million (197-202)
  • Table 195. Australia Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 196. Australia Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 197. Australia Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 198. Rest of Asia-Pacific Amblyopia Treatment, by Application USD Million (197-202)
  • Table 199. Rest of Asia-Pacific Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 200. Rest of Asia-Pacific Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 201. Rest of Asia-Pacific Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 202. Europe Amblyopia Treatment, by Country USD Million (197-202)
  • Table 203. Europe Amblyopia Treatment, by Application USD Million (197-202)
  • Table 204. Europe Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 205. Europe Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 206. Europe Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 207. Germany Amblyopia Treatment, by Application USD Million (197-202)
  • Table 208. Germany Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 209. Germany Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 210. Germany Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 211. France Amblyopia Treatment, by Application USD Million (197-202)
  • Table 212. France Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 213. France Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 214. France Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 215. Italy Amblyopia Treatment, by Application USD Million (197-202)
  • Table 216. Italy Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 217. Italy Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 218. Italy Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 219. United Kingdom Amblyopia Treatment, by Application USD Million (197-202)
  • Table 220. United Kingdom Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 221. United Kingdom Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 222. United Kingdom Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 223. Netherlands Amblyopia Treatment, by Application USD Million (197-202)
  • Table 224. Netherlands Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 225. Netherlands Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 226. Netherlands Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 227. Rest of Europe Amblyopia Treatment, by Application USD Million (197-202)
  • Table 228. Rest of Europe Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 229. Rest of Europe Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 230. Rest of Europe Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 231. MEA Amblyopia Treatment, by Country USD Million (197-202)
  • Table 232. MEA Amblyopia Treatment, by Application USD Million (197-202)
  • Table 233. MEA Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 234. MEA Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 235. MEA Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 236. Middle East Amblyopia Treatment, by Application USD Million (197-202)
  • Table 237. Middle East Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 238. Middle East Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 239. Middle East Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 240. Africa Amblyopia Treatment, by Application USD Million (197-202)
  • Table 241. Africa Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 242. Africa Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 243. Africa Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 244. North America Amblyopia Treatment, by Country USD Million (197-202)
  • Table 245. North America Amblyopia Treatment, by Application USD Million (197-202)
  • Table 246. North America Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 247. North America Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 248. North America Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 249. United States Amblyopia Treatment, by Application USD Million (197-202)
  • Table 250. United States Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 251. United States Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 252. United States Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 253. Canada Amblyopia Treatment, by Application USD Million (197-202)
  • Table 254. Canada Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 255. Canada Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 256. Canada Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 257. Mexico Amblyopia Treatment, by Application USD Million (197-202)
  • Table 258. Mexico Amblyopia Treatment, by Modern Treatment USD Million (197-202)
  • Table 259. Mexico Amblyopia Treatment, by Classical USD Million (197-202)
  • Table 260. Mexico Amblyopia Treatment, by Amblyopia USD Million (197-202)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amblyopia Treatment: by Application USD Million (2017-2022)
  • Figure 5. Global Amblyopia Treatment: by Modern Treatment USD Million (2017-2022)
  • Figure 6. Global Amblyopia Treatment: by Classical USD Million (2017-2022)
  • Figure 7. South America Amblyopia Treatment Share (%), by Country
  • Figure 8. Asia Pacific Amblyopia Treatment Share (%), by Country
  • Figure 9. Europe Amblyopia Treatment Share (%), by Country
  • Figure 10. MEA Amblyopia Treatment Share (%), by Country
  • Figure 11. North America Amblyopia Treatment Share (%), by Country
  • Figure 12. Global Amblyopia Treatment share by Players 2022 (%)
  • Figure 13. Global Amblyopia Treatment share by Players (Top 3) 2022(%)
  • Figure 14. Global Amblyopia Treatment share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 17. 3M (United States) Revenue: by Geography 2022
  • Figure 18. Vivid Vision, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Vivid Vision, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. NovaSight (Israel) Revenue, Net Income and Gross profit
  • Figure 21. NovaSight (Israel) Revenue: by Geography 2022
  • Figure 22. RevitalVision (Israel) Revenue, Net Income and Gross profit
  • Figure 23. RevitalVision (Israel) Revenue: by Geography 2022
  • Figure 24. Hilco Vision (United States) Revenue, Net Income and Gross profit
  • Figure 25. Hilco Vision (United States) Revenue: by Geography 2022
  • Figure 26. Krafty Eye Patches (United States) Revenue, Net Income and Gross profit
  • Figure 27. Krafty Eye Patches (United States) Revenue: by Geography 2022
  • Figure 28. Fresnel Prism and Lens Co. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Fresnel Prism and Lens Co. (United States) Revenue: by Geography 2022
  • Figure 30. OpthoPatch (United States) Revenue, Net Income and Gross profit
  • Figure 31. OpthoPatch (United States) Revenue: by Geography 2022
  • Figure 32. Lancastle International Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Lancastle International Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 34. HOYA Vision Care Company (Thailand) Revenue, Net Income and Gross profit
  • Figure 35. HOYA Vision Care Company (Thailand) Revenue: by Geography 2022
  • Figure 36. Global Amblyopia Treatment: by Application USD Million (197-202)
  • Figure 37. Global Amblyopia Treatment: by Modern Treatment USD Million (197-202)
  • Figure 38. Global Amblyopia Treatment: by Classical USD Million (197-202)
  • Figure 39. South America Amblyopia Treatment Share (%), by Country
  • Figure 40. Asia Pacific Amblyopia Treatment Share (%), by Country
  • Figure 41. Europe Amblyopia Treatment Share (%), by Country
  • Figure 42. MEA Amblyopia Treatment Share (%), by Country
  • Figure 43. North America Amblyopia Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M (United States)
  • Vivid Vision, Inc. (United States)
  • NovaSight (Israel)
  • RevitalVision (Israel)
  • Hilco Vision (United States)
  • Krafty Eye Patches (United States)
  • Fresnel Prism and Lens Co. (United States)
  • OpthoPatch (United States)
  • Lancastle International Ltd. (United Kingdom)
  • HOYA Vision Care Company (Thailand)
Additional players considered in the study are as follows:
Good-Lite (United States) , OrtopadUSA (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 239 Pages 77 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Amblyopia Treatment Market Quantitative research analysis
Global Amblyopia Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 202
Companies that are profiled in Global Amblyopia Treatment Market are 3M (United States), Vivid Vision, Inc. (United States), NovaSight (Israel), RevitalVision (Israel), Hilco Vision (United States), Krafty Eye Patches (United States), Fresnel Prism and Lens Co. (United States), OpthoPatch (United States), Lancastle International Ltd. (United Kingdom) and HOYA Vision Care Company (Thailand) etc.
Hospital segment in Global market to hold robust market share owing to "Nearly 3% of Amblyopia Treatment Remain Untreated ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Amblyopia Treatment market throughout the forecasted period.

Know More About Global Amblyopia Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Nonalcoholic Steatohepatitis Treatment Comprehensive Study by Type (Lifestyle Modifications, Dietary Changes, Exercise), Application (Health and Nutrition Tracking Apps, Medication Management Tools),...
$ 3450
Direct Endoscopic Necrosectomy Comprehensive Study by Type (Abdominal Scan, X-ray, Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Abdominal Biopsy, Urine test...
$ 3500
Lyme Disease Treatment Comprehensive Study by Type (Doxycycline, Amoxicillin, Cefuroxime axetil, Ceftriaxone, Others), Application (Humans, Animals), Disease (Early Lyme disease (absence of erythema ...
$ 3750
Acne Scar Treatment Comprehensive Study by Type (Laser Treatments, Minor Skin Surgeries, Chemical Peels, Fillers, Others), Application (Minimize Small Scars, Minor Skin Surface Irregularities, Surgic...
$ 3450
Genital Warts Treatment Comprehensive Study by Drug Type (Podophyllotoxin, Imiquimod, Sinecatechins, Podophyllin, 5-FU), Mechanism of Action (Immunomodulators, Immunomodulators; Virus Internalization...
$ 3650
Pancreatic Amylase Reagent Comprehensive Study by Function (Digestion Of Carbohydrate, Producing Glucose), Causes And Risk Factor (Autoimmune diseases, Drinking lots of alcohol, Infections, Gallstone...
$ 3750